Literature DB >> 29134

Marke's disease herpesviruses. III. Purification and characterization of Marek's disease herpesvirus B antigen.

L F Velicer, D R Yager, J L Clark.   

Abstract

Sera from chickens naturally infected with Marek's disease herpesvirus (MDHV) form preciptin lines with at least two immunologically distinct soluble antigens designated MDHV-A and MDHV-B. Partial purification and characterization of the glycoprotein MDHV-A antigen was previously reported. MDHV-B was found predominantly in the sonically treated extracts of infected cells, in contrast to the predominantly extracellular MDHV-A. Analysis of these extracts from [14C]glucosamine-labeled cells by immunodiffusion with chicken anti MDHV-B serum negative for MDHV-A followed by autoradiography confirmed that MDHV-B was a common antigen between MDHV and herpesvirus of turkeys and revealed that it was also a glycoprotein. Because of their glycoprotein nature, both MDHV-A and MDHV-B bound to concanavalin A affinity chromatography columns and could then be eluted by alpha-methyl-D-mannoside and recovered for further analysis. Concanavalin A affinity chromatography was an excellent technique for initial purification of MDHV-A and MDHV-B, since approximately 5- and 15- fold purification, respectively, was achieved in a single simple step. MDHV-B was resistant to trypsin under conditions where MDHV-A was sensitive, but was similar to MDHV-A in resistance to pH 2.0 and to 1.0 or 2.0 M urea and 0.05% Brij 35. Partially purified MDHV-B was analyzed by sucrose gradient sedimentation, isoelectric focusing, and gel filtration on Sephadex G-200 in the presence of 1.0 or 2.0 M urea and 0.05% Brij 35 to purify the antigen and to determine its physical and chemical properties in comparison with those already reported for MDHV-A. MDHV-B had a much lower isoelectric point in pH 4,54, a higher sedimentation coefficient of 4.4S, and a greater molecular weight of 58,250. These data indicate that MDHV-B is physically distinct from MDHV-A antigen, although the size difference is not sufficient to allow for effective separation. In contrast, the isoelectric point difference of greater than 2 pH units makes isoelectric focusing an effective means of purifying the antigens free of one another. The four-step purification procedure achieved greater than 200-fold purification of MDHV-B. Immunization of rabbits with this highly purified antigen results in the preparation of antisera that appeared monospecific for MDHV-B in immunodiffusion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29134      PMCID: PMC354153          DOI: 10.1128/JVI.27.1.205-217.1978

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Studies of Marek's disease herpesvirus and turkey herpesvirus specific common antigen which stimulates the production of neutralizing antibodies.

Authors:  M Onuma; T Mikami; T T Hayashi; K Okada; Y Fujimoto
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus.

Authors:  F Lesnik; L J Ross
Journal:  Int J Cancer       Date:  1975-07-15       Impact factor: 7.396

Review 3.  The role of herpesviruses in Marek's disease lymphoma of chickens.

Authors:  K Nazerian; L F Lee; J M Sharma
Journal:  Prog Med Virol       Date:  1976

4.  Surface antigen on chick kidney cells infected with the herpesvirus of Marek's disease.

Authors:  J H Chen; H G Purchase
Journal:  Virology       Date:  1970-02       Impact factor: 3.616

5.  Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines.

Authors:  P C Powell
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

6.  Demonstration of a Marek's disease tumor-associated surface antigen (MATSA) on six cell lines derived from Marek's disease lymphomas.

Authors:  H Matsuda; K Ikuta; H Miyamoto; S Kato
Journal:  Biken J       Date:  1976-09

7.  Serological relationship between a pathogenic strain of Marek's disease virus, its attenuated derivative and herpes virus of turkeys.

Authors:  L J Ross; O Basarab; D J Walker; B Whitby
Journal:  J Gen Virol       Date:  1975-07       Impact factor: 3.891

8.  Demonstration of a tumor-associated surface antigen in Marek's disease.

Authors:  R L Witter; E A Stephens; J M Sharma; K Nazerian
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

9.  Relation between common antigen and membrane antigens associated with Marek's disease herpesvirus and turkey herpesvirus infections.

Authors:  M Onuma; T Mikami; T T Hayashi
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

10.  Properties of feline leukemia virus. I. Chromatographic separation and analysis of the polypeptides.

Authors:  D C Graves; L F Velicer
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

View more
  8 in total

1.  Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoprotein.

Authors:  R J Isfort; R A Stringer; H J Kung; L F Velicer
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

2.  Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.

Authors:  C Glaubiger; K Nazerian; L F Velicer
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

3.  Molecular characterization of Marek's disease herpesvirus B antigen.

Authors:  R J Isfort; I Sithole; H J Kung; L F Velicer
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Characterization of the gene encoding herpesvirus of turkeys gp57-65: comparison to Marek's disease virus gp57-65 and herpes simplex virus glycoprotein C.

Authors:  P M Coussens; M R Wilson; H Camp; H Roehl; R J Isfort; L F Velicer
Journal:  Virus Genes       Date:  1990-04       Impact factor: 2.332

5.  Extensive homology exists between Marek disease herpesvirus and its vaccine virus, herpesvirus of turkeys.

Authors:  C P Gibbs; K Nazerian; L F Velicer; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  Marek's disease virus serotype-1 antigens A and B and their unglycosylated precursors detected by Western blot analysis of infected cells.

Authors:  I Davidson; M Malkinson; Y Becker
Journal:  Virus Genes       Date:  1988-10       Impact factor: 2.332

7.  Structure and complete nucleotide sequence of the Marek's disease herpesvirus gp57-65 gene.

Authors:  P M Coussens; L F Velicer
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

8.  Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV.

Authors:  M Niikura; Y Matsuura; D Endoh; M Onuma; T Mikami
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.